Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Regulatory securities lawsuit

Doximity Securities Fraud Class Action

Analysis based on 22 articles · First reported Sep 17, 2026 · Last updated Sep 23, 2026

Sentiment
-10
Attention
2
Articles
22
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The lawsuits add legal and reputational overhang to Doximity shares already battered by repeated guidance cuts and slowing growth, keeping downward pressure on investor confidence and valuation. Broader market impact is limited, as the matter is company-specific litigation rather than a systemic regulatory or macroeconomic event.

healthcare technology legal services financial services

Multiple investor-rights law firms have filed or announced securities class action lawsuits against Doximity, Inc. (NYSE: DOCS) and certain of its officers, alleging violations of federal securities laws during the Class Period of August 8, 2024 through May 13, 2026. The complaints allege that Doximity overstated the impact of its Newsfeed on revenue growth, was losing market share to competitors with more favorable pricing and engagement models, and relied heavily on banner advertisements and email newsletters rather than deeper engagement tactics, rendering statements about its Newsfeed, revenue growth, market position, engagement, and advertising practices materially false or misleading. The alleged disclosures triggered sharp stock declines: shares fell 13.25% to $54.29 on November 7, 2025 after cautious ad-spending commentary; fell 16.78% to $27.73 on February 6, 2026 after lowered revenue guidance; and fell 23% to $18.01 on May 14, 2026 after missing already-reduced guidance and projecting slower fiscal 2027 growth. Pomerantz LLP, Bronstein, Gewirtz & Grossman, LLC, LLC, and Rosen Law Firm have each issued notices encouraging investors to seek lead plaintiff appointment by the November 16, 2026 deadline. No class has been certified.

90 Pomerantz LLP filed class action Doximity
75 Doximity missed revenue guidance
70 Doximity lowered revenue guidance
70 Rosen Law Firm filed class action lawsuit Doximity
stock
Doximity is the sole defendant in the securities class actions, facing allegations of misleading statements on Newsfeed impact, market share, and advertising practices. The litigation compounds its already weak stock performance, which fell from $54.29 to $18.01 across three disclosure events.
Importance 100.0 Sentiment -55.0
priv
Pomerantz LLP announced the class action against Doximity and is soliciting investors to seek lead plaintiff appointment by November 16, 2026.
Importance 45.0 Sentiment 5.0
priv
Bronstein, Gewirtz & Grossman, LLC, LLC announced the class action and is recruiting Doximity investors for the lead plaintiff role ahead of the November 16, 2026 deadline.
Importance 45.0 Sentiment 5.0
priv
Rosen Law Firm announced the class action on behalf of Doximity purchasers and is encouraging investors to join and seek lead plaintiff appointment by November 16, 2026.
Importance 45.0 Sentiment 5.0
per
Founding partner of Bronstein, Gewirtz & Grossman, LLC, quoted on the firm's investor-rights practice and serves as contact for the Doximity case.
Importance 40.0 Sentiment 0.0
per
Client relations manager listed as a contact for investors seeking information about the Doximity class action.
Importance 15.0 Sentiment 0.0
exch
The NYSE is the listing venue for Doximity shares (DOCS), which experienced sharp declines tied to the alleged disclosures underlying the litigation.
Importance 10.0 Sentiment 0.0
Pomerantz LLP co-plaintiffs ↔ Bronstein, Gewirtz & Grossman, LLC Pomerantz LLP frequently acts as co-plaintiff with Bronstein, Gewirtz & Grossman, LLC in numerous securities class actio
Pomerantz LLP co-plaintiff ↔ Rosen Law Firm Pomerantz LLP frequently acts as a co-plaintiff with Rosen Law Firm in numerous investor-rights class action lawsuits ag
Bronstein, Gewirtz & Grossman, LLC co-counsel ↔ Rosen Law Firm Bronstein, Gewirtz & Grossman, LLC frequently collaborates with Rosen Law Firm as co-counsel on investor-rights class ac
Peretz Bronstein principal ↔ Nathan Miller Peretz Bronstein is the founding partner of Bronstein, Gewirtz & Grossman, LLC, and acts as a principal for Nathan Mille
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.